Envestnet Portfolio Solutions
LGND icon

Envestnet Portfolio Solutions’s Ligand Pharmaceuticals LGND Stock Holding History

Envestnet Portfolio Solutions’s Portfolio LGND Stock Details LGND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$328K Buy
+1,039
New +$245K ﹤0.01% 1145
2026
Q1 		– Sell
-1,407
Closed -$266K – 1416
2025
Q4 		$266K Sell
1,407
-153
-10% -$29.4K ﹤0.01% 1348
2025
Q3 		$276K Buy
+1,560
New +$232K ﹤0.01% 1289

Other funds holding LGND

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $15.4B AUM 30.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Envestnet Portfolio Solutions's LGND Position: Q2 2026 in Review

Envestnet Portfolio Solutions opened a new position in Ligand Pharmaceuticals (LGND) in Q2 2026: 1,039 shares worth $328K. The stake represents ﹤0.01% of the portfolio and ranks #1145 among its holdings. This is a return to the name: Envestnet Portfolio Solutions previously reported a position in LGND as recently as Q4 2025.

Envestnet Portfolio Solutions first reported a position in LGND in Q3 2025 and has held it in 3 quarters since. 417 funds tracked by Wall St. Rank hold LGND as of Q2 2026.

  • Envestnet Portfolio Solutions held 1,039 shares of Ligand Pharmaceuticals worth $328K as of Q2 2026.
  • Ligand Pharmaceuticals was a new Envestnet Portfolio Solutions position in Q2 2026.
  • Ligand Pharmaceuticals made up ﹤0.01% of Envestnet Portfolio Solutions's portfolio in Q2 2026, its #1145 holding.
  • Envestnet Portfolio Solutions first reported a position in Ligand Pharmaceuticals in Q3 2025 and has held it in 3 quarters since.
  • 417 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q2 2026.

Based on Envestnet Portfolio Solutions's 13F filing for Q2 2026, filed 20 Jul 2026.